SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Former Special Forces soldier, Jason Fox, partners with fourfive CBD

    By
    Home / Former Special Forces soldier, Jason Fox, partners with fourfive CBD

    CBD and wellness brand, fourfive, has announced its partnership with the presenter of SAS: Who Dares Wins star and former UK Special Forces soldier, Jason Fox.

    Founded by professional rugby players George Kruis and Dom Day in 2018, fourfive is partnering with TV presenter and former Special Forces solider, Fox.

    The partnership was inspired in 2019 when fourfive co-founder and ex-professional England rugby player, George Kruis, introduced Jason Fox to fourfive’s cannabidiol (CBD) following disrupted sleep the presenter endured during a trip to Yukon. Jason has now teamed up with fourfive to share his experience with CBD.

    Read more: fourfive – The story of two rugby players who decided to tackle the CBD business

    Since he first tried CBD, Fox, often referred to as “Foxy”, has included CBD spray oil and muscle rub in his daily routine to improve his sleep and ease body pains.

    Fox commented: “I was very sceptical. I’d heard about this and that, so George sent some CBD to me within a few days of getting back from the trip. At the time, my sleep pattern was screwed and I never slept very well before that anyway. 

    “I thought I’d be in a state for a while with the time difference, the routine that I had out there, not being in darkness and I was all over the place.

    “I got the spray CBD oil and started using it and within days my sleep pattern was back. Not only that, my Mrs said I was much more chilled out, my fuse is longer, and I was a nicer person to be around. I’m actually a better person from it and now I have it with me all the time.”

    Fourfive co-founder and ex-professional Welsh rugby union player, Dom Day said: “I am personally a big fan of what Foxy has achieved in the forces, during his appearances on SAS: Who Dares Wins, but most importantly in the work he does to support people with PTSD and with mental health problems. 

    “With his genuine positive experiences of using CBD products and also his past support of fourfive, we are really delighted to have him as part of the team.”

    Kruis added: “Working with people that you like is always a bonus but to bring on board someone like Foxy who I have the utmost respect for, both personally and professionally, is a great step for fourfive. We’re delighted to support his ongoing journey with mental health and PTSD and to help raise awareness in these areas.”

    [activecampaign form=31]

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free